Quanterix Announces Commercial Availability of Its Simoa Single Molecule Array Technology
7/30/2013 9:54:55 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
LEXINGTON, Mass.--(BUSINESS WIRE)--Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today unveiled its Single Molecule Array (Simoa) technology at the 2013 AACC Annual Meeting in Houston, Texas, making it commercially available for the first time on a fully automated platform for research use only. With Simoa, life science researchers will be empowered to explore biomarkers and pathways with greater sensitivity and precision, paving the way for the development of new diagnostic tests and improved treatment of diseases in oncology, neurology, cardiology and other fields of medicine.
Help employers find you! Check out all the jobs and post your resume.
comments powered by